Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Similar articles for PubMed (Select 22069063)

1.

Silencing disease genes in the laboratory and the clinic.

Watts JK, Corey DR.

J Pathol. 2012 Jan;226(2):365-79. doi: 10.1002/path.2993. Epub 2011 Nov 9. Review.

2.

Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies.

Bhindi R, Fahmy RG, Lowe HC, Chesterman CN, Dass CR, Cairns MJ, Saravolac EG, Sun LQ, Khachigian LM.

Am J Pathol. 2007 Oct;171(4):1079-88. Epub 2007 Aug 23. Review.

3.

Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA.

Mahato RI, Cheng K, Guntaka RV.

Expert Opin Drug Deliv. 2005 Jan;2(1):3-28. Review.

PMID:
16296732
4.

Conjugates of oligonucleotides and analogues with cell penetrating peptides as gene silencing agents.

Zatsepin TS, Turner JJ, Oretskaya TS, Gait MJ.

Curr Pharm Des. 2005;11(28):3639-54. Review.

PMID:
16305500
5.

Designing chemically modified oligonucleotides for targeted gene silencing.

Deleavey GF, Damha MJ.

Chem Biol. 2012 Aug 24;19(8):937-54. doi: 10.1016/j.chembiol.2012.07.011. Review.

6.

Nucleic-acid therapeutics: basic principles and recent applications.

Opalinska JB, Gewirtz AM.

Nat Rev Drug Discov. 2002 Jul;1(7):503-14. Review.

PMID:
12120257
7.

Antisense, RNAi, and gene silencing strategies for therapy: mission possible or impossible?

Rayburn ER, Zhang R.

Drug Discov Today. 2008 Jun;13(11-12):513-21. doi: 10.1016/j.drudis.2008.03.014. Epub 2008 May 3. Review.

8.

Nucleic acid modulation of gene expression: approaches for nucleic acid therapeutics against cancer.

Nakata Y, Kim TK, Shetzline S, Gewirtz AM.

Crit Rev Eukaryot Gene Expr. 2005;15(2):163-82. Review.

PMID:
16022634
9.

Progress in the development of nucleic acid therapeutics for cancer.

Kalota A, Shetzline SE, Gewirtz AM.

Cancer Biol Ther. 2004 Jan;3(1):4-12. Epub 2004 Jan 18. Review.

10.

Antisense oligonucleotides: the state of the art.

Aboul-Fadl T.

Curr Med Chem. 2005;12(19):2193-214. Review.

PMID:
16178780
11.

Targets and tools: recent advances in the development of anti-HCV nucleic acids.

Romero-López C, Sánchez-Luque FJ, Berzal-Herranz A.

Infect Disord Drug Targets. 2006 Jun;6(2):121-45. Review.

PMID:
16789875
12.

Is there a future for cell-penetrating peptides in oligonucleotide delivery?

Lee SH, Castagner B, Leroux JC.

Eur J Pharm Biopharm. 2013 Sep;85(1):5-11. doi: 10.1016/j.ejpb.2013.03.021. Review.

PMID:
23958313
13.

Therapeutic potential of antisense nucleic acid molecules.

Opalinska JB, Gewirtz AM.

Sci STKE. 2003 Oct 28;2003(206):pe47. Review.

PMID:
14583589
14.

RNA interference in mammalian cell systems.

Lochmatter D, Mullis PE.

Horm Res Paediatr. 2011;75(1):63-9. doi: 10.1159/000322817. Epub 2011 Jan 17. Review.

PMID:
21252559
15.

Oncogene-targeted antisense oligonucleotides for the treatment of Ewing sarcoma.

Maksimenko A, Malvy C.

Expert Opin Ther Targets. 2005 Aug;9(4):825-30. Review.

PMID:
16083345
16.

Nucleic acid therapeutics: a work in progress.

Opalinska JB, Gewirtz AM.

Curr Opin Investig Drugs. 2002 Jun;3(6):928-33. Review. No abstract available.

PMID:
12137416
17.

Combinatorial application of nucleic acid-based agents targeting protein kinases for cancer treatment.

Spänkuch B, Strebhardt K.

Curr Pharm Des. 2008;14(11):1098-112. Review.

PMID:
18473857
18.

Applying small RNA molecules to the directed treatment of human diseases: realizing the potential.

Pappas TC, Bader AG, Andruss BF, Brown D, Ford LP.

Expert Opin Ther Targets. 2008 Jan;12(1):115-27. Review.

PMID:
18076375
19.

Clinical applications of aptamers and nucleic acid therapeutics in haematological malignancies.

Shigdar S, Ward AC, De A, Yang CJ, Wei M, Duan W.

Br J Haematol. 2011 Oct;155(1):3-13. doi: 10.1111/j.1365-2141.2011.08807.x. Epub 2011 Aug 2. Review.

PMID:
21810089
20.

Oligomeric nucleic acids as antivirals.

Mescalchin A, Restle T.

Molecules. 2011 Jan 28;16(2):1271-96. doi: 10.3390/molecules16021271. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk